TurtleTree
PrivateLast Round
Strategic
Jul 8, 2026
Est. Valuation
$390M
Total Funding Raised
$43.85M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
TurtleTree is a biotechnology company that develops precision fermentation technology to produce sustainable, animal-free dairy ingredients, including lactoferrin.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Sustainable Materials
Business Model
B2B
Customer Profile
Usage-Based SaaS, Data as a Service, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TurtleTree Comparables
Compare TurtleTree with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| All G | 90% | |
| Helaina | 88% | |
| Imagindairy | 86% |
TurtleTree Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jul 8, 2026 | ||||
| Grant | Sep 19, 2023 | ||||
| Series A | Nov 1, 2021 | ||||
| Seed | Dec 17, 2020 | ||||
| Grant | Oct 19, 2020 | ||||
Grant | Jul 8, 2020 |
Key People
Founding team and executive leadership
TurtleTree Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KBW Ventures | Seed, Pre Seed |
| NIH RADx | Grant |
| Green Monday Ventures | Seed |
| CPT Capital | Seed |
| Temasek Foundation | Grant |
| Artesian | Series A, Seed |
| ACRE | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 8, 2026
Novonesis and Steve Melhuish participated in the round.
- Nov 1, 2021
$33M round led by Verso Capital
Recent news
Latest coverage and updates
- closes_offices_inOct 29, 2026
Turtletree moves its global headquarters from Singapore to the Netherlands and bases its work at Nizo’s Food Innovation Park in the Dutch Food Valley.
TurtleTree Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about TurtleTree's valuation, stock price, and market status.
Is TurtleTree a public or private company?
TurtleTree is a private company.
What is the current stock price of TurtleTree?
TurtleTree is a private company, so its shares have no public market price. Caplight tracks TurtleTree's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is TurtleTree worth (valuation)?
TurtleTree's valuation is estimated at $390.0M based on funding round data.
Can I buy TurtleTree stock?
TurtleTree shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was TurtleTree's last funding round?
TurtleTree's most recent funding round was Strategic on July 8, 2026.
Who are the main investors in TurtleTree?
Key investors in TurtleTree include Lever VC, Verso Capital.
Will TurtleTree IPO soon?
No public IPO plans have been announced for TurtleTree.
How can I track TurtleTree secondary market activity?
Caplight tracks bids, offers, and trades in TurtleTree's shares on secondary markets.